Leukomed® Sorbact®
  • Product
  • Indications
  • Features & Benefits
  • Ordering Information
  • Styles
  • Lower Limb Styles
  • Lower Limb Options
  • Upper Limb Styles
  • Upper Limb Options
  • Patient
  • Clinical
  • Options
  • Application

Sorbact Technology-coated microbial binding post-op dressings

Leukomed Sorbact is an innovative surgical post-operative film dressing which has a purely physical mode of action, that reduces bacterial colonisation.
The dressing has demonstrated proven effectiveness in various clinical studies1,2

  • Clinically significant 65% relative risk reduction of acquiring a surgical site infection post-caesarean section1
  • Up to 57% cost reduction when treating caesarean sections, using NHS cost model3
  • Effective reduction of the bacterial burden in colonised or locally infected wounds4

New medical technologies guidance from NICE recommends that Leukomed Sorbact should be considered as an option for preventing surgical site infection   (SSI ) in wounds with low to moderate exudate post caesarean and vascular surgery and that it should be used as part of usual measures to help reduce the risk of SSI*. 

To read the full guidance please visit: www.nice.org.uk/guidance/mtg55

For more information please email support.leukomedsorbact@leukoplast.com 

  1. Stanirowski J, Bizon M, Cendrowski K, et al (2016b) Randomized controlled trial evaluating dialkylcarbamoyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing caesarean section. Surg Infect (Larchmt) 17(4): 427 -35.
  2. Bua N, et al. Dialkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017 Oct:44:387-392.
  3. Stanirowski PJ, Davies H, McMaster J, Mealing S, Sawicki W, Cendrowski K, Posnett J. Cost-effectiveness of a bacterial-binding dressing to prevent surgical site infection following caesarean section. Journal of Wound Care. 2019 Apr 2;28(4):222-228.
  4. Cutting K, Maguire J (2015) Safe bioburden management. A clinical review of DACC technology. Journal of Wound Care Vol 24, No 5.

*© NICE 2021 Leukomed Sorbact for preventing surgical site infection. Available from
www.nice.org.uk/guidance/mtg55. All rights reserved. Subject to Notice of rights. 
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

Leukomed® Sorbact® - For post-operative and traumatic wounds that are dry or have low exudate levels:

  • Surgical incisions
  • Lacerations, cuts and abrasions

Helps to minimise the risk of infection

Adhesive film

  • Breathable and shower-proof
  • Provides high patient comfort
  • Reliable adhesion
  • Dressing stays securely in place 

Absorbent wound pad

  • Absorbs low to moderate exudate levels
  • Reduces the risk of maceration 

Sorbact Technology-coated microbial binding wound contact layer

  • Safely and effectively binds bacteria and fungi using a hydrophobic fatty acid. It binds the hydrophobic microbes by physical interaction in a moist environment
  • No chemically active agents
  • Can be used safely on all patient groups and used prophylactically to reduce risk of infection


CodeSizePad SizeNHS SC Code
76199-005cm x 7.2cm3cm x 4cmELY578
76199-018cm x 10cm4cm x 6cmELY579
76199-028cm x 15cm4cm x 11cmELY580
76199-0310cm x 20cm5cm x 16cmELY581
76199-0410cm x 25cm5cm x 20.5cmELY582
76199-0510cm x 30cm5cm x 25cmELY583
76199-0610cm x 35cm5cm x 30cmELY584
  • Taylor L, Mills E, George S, Seckam A (2020) Reducing SSI rates for women birthing by caesarean section. J Community Nurs 34(3): 50–3, click here to access
  • Wounds UK (2020) Best Practice Statement: Post-operative wound care – reducing the risk of surgical site infection. Wounds UK, London, click here to access

For more information supporting the use of Leukomed Sorbact in the prevention of SSI please get in touch and email support.leukomedsorbact@leukoplast.com or call 01482 670711.